Fitzgerald Joseph Michael

EVP & Group Pres, Cardiology

Fitzgerald Joseph Michael has filed 5 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.

Companies traded

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$9.9M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BSXSale$5.0MNov 4SEC ↗
BSXSale$4.9MOct 1SEC ↗